期刊文献+

血清CA125测定在上皮性卵巢癌病情监测中的作用 被引量:6

下载PDF
导出
摘要 血清CA125是上皮性卵巢癌(EOC)最常用的肿瘤标志物,虽然CA125不能单独筛选或早期诊断EOC,但不失为追踪监测病情的一个重要指标,血清CA125水平的升降与EOC的疾病状态密切相关。近年来,对血清CA125值能否预测初次理想减灭术,能否反映化疗疗效及血清CA125反应与进展标准的提出,对预后的评估,早期判断复发等各方面进行了大量的研究,综述血清CA125在EOC病情监测中作用的研究进展。
出处 《国外医学(计划生育分册)》 2005年第2期90-94,共5页
  • 相关文献

参考文献20

  • 1Yin BW,Lloyd KO.Molecular cloning of the CA125 ovarian cancer antigen identification as a new mucin,MUC 16.J Biol Chem,2001,276(29):27371-27375.
  • 2O'Bfien TJ,Beard JB,Underwood LJ,et al.The CA125 gene:an estracellular superstructure dominated by repeat sequences.Tumor Biol,2001,22(6):348-366.
  • 3Kaneko SJ, Gerasimova T,Smith ST,et al.CA125 and UQCRFS1 FISH studies of ovarian carcinoma.Gynecol Oncol,2003,90(1):29-36.
  • 4Chi DS, Venkatraman ES, Masson V, et al.The ability of preoperative serum CA125 to predict optimal primary tumor cytoreduction in stage Ⅲ epithelial ovarian carcinoma.Gynecol Oncol,2000, 77(2):227-231.
  • 5Cooper BC, Sood AK, Davis CS,et al.Preoperative CA125 levels: an independent prognostic factor for epithelial ovarian cancer.Obstet Gynecol,2002,100(1 ):59-64.
  • 6Obeidat B, Latimer J, Crawford R.Can optimal primary eytoreduetion be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA125 level.Gynecol Obstet Invest, 2004,57(3):153-156.
  • 7Leitao M, Boyd J. Preoperative CA125 levels in patients with hereditary compared to sporadic epithelial ovarian carcinoma.Gynecol Oncol,2002, 84(3):413-415.
  • 8Rossi AC, Di Vagno G, Cormio G,et al. A retrospective study of preoperative CA125 levels in 82 patients with ovarian cancer. Arch Gynecol Obstet,2004,269(4):263-265.
  • 9Guppy AE, Rustin GJS.CA125 Response:Can it replace the traditional response criteria in ovarian cancer? Oncol,2002,7(5):437-443.
  • 10Paulsen T, Marth C, Kaern J, et al. Effects of paclitaxel on CA125 serum levels in ovarian cancer patients.Gynecol Oncol,2000,76(3):326-330.

同被引文献46

  • 1孔凡荣,王黎明,戴淑真,孙显璐,吕艳华.B7-H4、CA_(125)及P53在上皮性卵巢癌中的表达及意义[J].山东大学学报(医学版),2009,47(2):74-77. 被引量:4
  • 2倪芳,鲁茁壮,瞿成奎,胡泽斌,王立生,汪思应.hTERT核心启动子驱动的条件复制型腺病毒载体的构建及鉴定[J].安徽医科大学学报,2006,41(1):19-22. 被引量:1
  • 3徐怡,黄艳春,雷君,吉军.血清CA125检测对恶性肿瘤的临床诊断价值[J].新疆医科大学学报,2007,30(1):69-71. 被引量:7
  • 4万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 5O′Brien T J,Beard J B,Underwood L J,et al.The CA 125 gene:an extracellular superstructure dominatedby repeat sequences[J].Tumour Biol,2001,(22):348-66.
  • 6O′Brien T J,Beard J B,Underwood L J,et al.The CA 125gene:a newly discovered extension of the glycosylated Nterminaldomain doubles the size of this extracellular superstructure[J].Tumour Biol,2002,(23):154-69.
  • 7Kui Wong N,Easton R L,Panico M,et al.Characterizationof the oligosaccharides associated with the humanovarian tumor marker CA125[J].Biol Chem,2003,(278):28619-34.
  • 8Brien O,Timothy.Monoclonal antibodies which identify the glycoprotein carrying the CA125 epitope[J].United States,1991,(165):1857-64.
  • 9Rustin G J,Marples M,Nelstrop A E,et al.Use of CA125 to define progression of ovarian cancer in patients with persist-ently elevated levels[J].Clin Oncol,2001,(19):4054-7.
  • 10Jennifer A A,Jennifer B,Masanori O,et al.Mesothelin-MUC16 binding is a high affinity,N-glycan dependentinteraction that facilitates peritoneal metastasis of ovaria tumors[J].Molecular Cancer,2006,5(1):51.

引证文献6

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部